Stay updated on JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial
Sign up to get notified when there's something new on the JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F7_6Qiw6iaK9CI8G_OknsayVkV70.uncropped.jpg&w=3840&q=75)
Latest updates to the JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial page
- ChecktodayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0, with the previous version v2.9.7 now removed.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less Drug Information available for: Pitavastatin FDA Drug and Device Resources Show less Design Details Allocation : N/A Interventional Model : Single Group Assignment Masking : None (Open Label) Arms and Interventions Participant Group/Arm Intervention/Treatment Experimental : Pitavastatin Then JNJ-63623872 Participants will sequentially receive single oral dose of pitavastatin 1 milligram (mg) on Day 1, followed by JNJ-63623872 600 mg twice daily on Days 4 through 12 with a single oral dose of pitavastatin 1 mg administered in the morning of Day 9. All study drug intakes will be taken orally, under fed conditions (within approximately 10 minutes after completion of a meal). Drug : Pitavastatin Participants will receive single oral dose of pitavastatin 1 milligram (mg) on Day 1 and Day 9. Drug : JNJ-63623872 Participants will receive JNJ-63623872 600 mg twice daily on Days 4 through 12.' This change represents an update in the drug information and study design details for the clinical trial involving Pitavastatin and JNJ-63623872.SummaryDifference76%
Stay in the know with updates to JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial page.